Everolimus in Breast Cancer Patients After Pre-operative Chemotherapy

Summary

This is a randomized controlled pilot study investigating signals involved in drug resistance to chemotherapy. Patient will be randomized to undergo observation or to receive Everolimus after completion of neoadjvuant treatment (anthracycline and/or taxane-based) and before surgery. The patients will be monitored for efficacy and safety.

Timeline

Start

2009-11

Primary completion

2012-12

Completion

2013-03

Drugs

Indications